NEW REPORT: The Heavy Price of GLP-1 Drugs: How Financialization Drives Pharmaceutical Patent Abuse and Health Inequities for GLP-1 Therapies

Contact Us

Got a question? Have something you want to tell us?
Please email us!

Initiative for Medicines, Access, and Knowledge
16192 Coastal Hwy., Lewes, DE 19958

Except for publications commissioned or published by third parties all content on this site is licensed under a Creative Commons Attribution 3.0 License.

Search for: